FRAXA's Impact to Date

$
0
32,306,347

Direct Investment in Fragile X Research

0
5

ONGOING FRAGILE X CLINICAL TRIALS AND STUDIES

Current Clinical Trials
0
39

TEAMS ACTIVELY RESEARCHING FRAGILE X

Current Research Grants
0
4

GENE THERAPY AND PROTEIN REPLACEMENT STUDIES

Current Studies
0
31

PHARMACEUTICAL AND BIOMEDICAL PARTNERS

0
617

RESEARCH GRANTS AWARDED

0
19

COUNTRIES ARE HOME TO RESEARCH TEAMS

What is Fragile X Syndrome?

Fragile X syndrome (FXS) is the most common inherited cause of autism and intellectual disabilities. It affects 1 in 4,000 boys and 1 in 8,000 girls worldwide.

Fragile X syndrome occurs when a single gene on the X chromosome shuts down. This gene makes a protein needed for normal brain development. In FXS it does not work properly, the protein is not made, and the brain does not develop as it should.

Learn more about Fragile X syndrome

How Does FRAXA Help?

FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments.

Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders.

Donate to FRAXA's mission

Latest Fragile X News & Updates

View all News & Updates

Making Drug Development Efficient Through Community-Based Collaboration

FRAXA co-founders Katie Clapp and Mike Tranfaglia, spoke virtually at the 5th Pharma Pricing Reimbursement and Market Access 2021 conference. In this session, facilitated by Nadia Bodkin, PharmD, MS, from the Rare Advocacy Movement, Katie and Mike were joined by Christopher U. Missling, PhD, President and CEO of Anavex Life Sciences Corp. to discuss the collaboration between FRAXA and Anavex as a case study example to help raise awareness amongst others in the rare disease industry of these types of collaborations between advocacy and industry.
Read more

7th Annual 5K Walk for Fragile X in NH Raises Over $3200 For Fragile X Research

Derry, New Hampshire served as the picturesque location for the 7th Annual 5K Walk for Fragile X syndrome and Raffles to support FRAXA Research Foundation. On September 12, 2021, around 50 individuals came together to show their support and make a difference in the lives of those with Fragile X syndrome. This year’s walk, which included raffle drawings with baskets and gift cards thanks to the generosity of local businesses and friends, raised over $3,200 for FRAXA to support the funding of effective treatments and ultimately a cure for Fragile X.
Read more

2021 Fragile X Research Grants Funded by FRAXA Research Foundation

Each year, FRAXA funds a diverse portfolio of research. Our FRAXA Fellowships are seed funding for the future, the feedstock for the Fragile X treatment development pathway. While we are looking to promote as many promising new approaches as possible, prominent themes emerge each year, as scientists around the world tackle previously neglected areas.
Read more

Upcoming Events

View full event calendar
No event found!
Share via
Copy link